Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Datasea Inc. (NASDAQ: DTSS) and iPower Inc. (NASDAQ: IPW) Collaborate to Expand Product Distribution in US Online Markets 2024-04-22 22:00
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial 2024-04-22 20:30
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns 2024-04-22 20:00
Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems 2024-04-22 20:00
Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19 2024-04-22 19:52
Leo Cancer Care Teams up With World-Leading Carbon Ion Centre 2024-04-22 18:43
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer 2024-04-22 17:51
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions 2024-04-22 16:00
GT20029 China Phase II Trial For AGA Reached Primary Endpoint 2024-04-22 09:53
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards 2024-04-22 09:00
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards 2024-04-22 09:00
BGI Genomics Leads Innovation with Inaugural Clinical Lab in Uruguay 2024-04-22 08:27
CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US 2024-04-20 01:11
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success 2024-04-19 21:00
Concord Medical Files 2023 Annual Report on Form 20-F 2024-04-19 20:31
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 2024-04-19 19:00
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer 2024-04-19 19:00
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization 2024-04-19 13:17
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization 2024-04-19 10:54
Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions 2024-04-18 21:00
1 2 3 4 5 890